<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">924</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-1-2-3-25-27</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Major trends in the antiulcer drugs market</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Beregovykh</surname><given-names>Roman</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prozherina</surname><given-names>Yuliya</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pavlova</surname><given-names>Nadezhda</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><aff id="aff-2">Yevdokimov Moscow State University of Medicine and Dentistry</aff><pub-date date-type="epub" iso-8601-date="2020-12-01" publication-format="electronic"><day>01</day><month>12</month><year>2020</year></pub-date><issue>1-3</issue><fpage>25</fpage><lpage>27</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>Over the past few decades, gastric and duodenal ulcer disease (UD) has remained one of the common reasons for outpatient care [1]. Whereas, the improvement of approaches to the treatment of this pathology and development of effective therapy methods open up new possibilities for patients. This article depicts the main trends in the pharmacy antiulcer drugs market.</abstract><kwd-group xml:lang="en"><kwd>ulcer disease</kwd><kwd>proton pump inhibitors</kwd><kwd>omeprazole</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>язвенная болезнь</kwd><kwd>ингибиторы протонного насоса</kwd><kwd>омепразол</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ширинская Н.В. Язвенная болезнь желудка и двенадцатиперстной кишки в Российской Федерации. Заболеваемость и смертность. Дальневосточный медицинский журнал. 2016;(3):105-109. Режим доступа: http://www.fesmu.ru/dmj/20163/2016324.aspx.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sachs G. Proton pump inhibitors and acid-related diseases. Pharmacotherapy. 1997;17(1):22-37. Available at: https://www.ncbi.nlm.nih. gov/pubmed/9017763.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Huang J.-Q., Hunt R.H. Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Pract Res Clin Gastroenterol. 2001;15(3):355-370. doi: 10.1053/ bega.2001.0184.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Минушкин О.Н., Масловский Л. В. Омепразол в терапии кислотозависимых заболеваний. Медицинский совет. 2015;(3):8-13. doi: 10.21518/2079-701X-2015-13-8-13</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Armstrong D., Sifrim D. New pharmacologic approaches in gastroesophageal reflux disease. Gastroenterol Clin N Am. 2010;(39):393-418. doi: 10.1016/j.gtc.2010.08.019.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Карева Е.Н., Сереброва С.Ю. Медикаментозное лечение нарушений моторики желудка - проблемы, пути решения, достижения. Экспериментальная и клиническая гастроэнтерология. 2017;(7):167-170. Режим доступа: http://nogr.org/images/Article/2017/G_07_2017_ In-21_167-183.pdf. 2020;(1-2-3) | remedium</mixed-citation></ref></ref-list></back></article>
